Silexion Therapeutics Ltd. (SLXN) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Silexion Therapeutics Ltd...

    NASDAQ: SLXN · Real-Time Price · USD
    7.28
    0.02 (0.28%)
    At close: Aug 28, 2025, 9:43 AM

    Silexion Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -16.52M -5.11M -3.49M -755.22K
    Depreciation & Amortization
    		 25K 45K 57K n/a
    Stock-Based Compensation
    		 5.86M 130K 125K n/a
    Other Working Capital
    		 -2.19M -10K 317K -469.68K
    Other Non-Cash Items
    		 3.82M 317K -268K -182.34K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -1.58M 87K 239K -469.68K
    Operating Cash Flow
    		 -8.4M -4.53M -3.33M -1.41M
    Capital Expenditures
    		 -22K -12K -40K -4
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a -500K n/a
    Sales Maturities Of Investments
    		 n/a 507K 16K n/a
    Other Investing Acitivies
    		 n/a 78K n/a n/a
    Investing Cash Flow
    		 -22K 573K -524K n/a
    Debt Repayment
    		 -250K n/a n/a 150.01K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 2.3M n/a 3K -2.55M
    Financial Cash Flow
    		 5.1M 522K 2.75M 116.4M
    Net Cash Flow
    		 -3.38M -3.66M -1.77M -12.76K
    Free Cash Flow
    		 -8.42M -4.54M -3.38M -1.41M

    Add to Watchlist